Hupe M, Ahuja D, Yeh KH, Patel SB, et al. Upadacitinib Is Associated with the Lowest Risk of Treatment Failure Among Advanced Therapies for Ulcerative Colitis: A Real-World Administrative Claims Study. Clin Gastroenterol Hepatol 2026 Sep 29:S1542-3565(26)00723.
PMID: 42810421